Neopharm Obesity Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Neopharm Obesity General Information
Description
Operator of a firm intended for the development and research of genomic medicine based in Spain.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
- Seville
- Spain
Primary Industry
Biotechnology
Acquirer
Corporate Office
- Seville
- Spain
Neopharm Obesity Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Neopharm Obesity FAQs
-
Where is Neopharm Obesity headquartered?
Neopharm Obesity is headquartered in Seville, Spain.
-
What industry is Neopharm Obesity in?
Neopharm Obesity’s primary industry is Biotechnology.
-
Is Neopharm Obesity a private or public company?
Neopharm Obesity is a Private company.
-
What is Neopharm Obesity’s current revenue?
The current revenue for Neopharm Obesity is .
-
When was Neopharm Obesity acquired?
Neopharm Obesity was acquired on 01-Jan-2013.
-
Who acquired Neopharm Obesity?
Neopharm Obesity was acquired by Landsteiner Scientific.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process